Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Evaluering af patientrapporterede udfaldsmålingsinformationssystem (PROMIS)-29 v2.1 for postpartum kvinder

There is no widely used, statistically validated assessment for physical and mental health for the short- to medium-term in a postpartum population. PROMIS-29 has been validated for the assessment of these factors in a generic population, but has not been specifically evaluated for use with postpartum women.

This study is a longitudinal, single center observational cohort study designed to evaluate the reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 survey in a postpartum population. PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living. While this survey has shown utility in other populations, it has yet to be assessed in an obstetric population. The investigators plan to recruit patients who are recently postpartum from vaginal or cesarean delivery to complete virtual surveys at defined time points (0, 2, 6, and 12 weeks after delivery). The investigators will subject survey data to statistical measures of validity and reliability comparing with contemporaneously collected surveys of established metrics for quality of life (WHOQoLBREF) and general (global) state of health (numerical rating score 1-100).

The hypothesis is that the PROMIS-29 v2.1 questionnaire is a statistically valid and reliable means of assessing physical and mental health in a postpartum population.

Studieoversigt

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

200

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Ontario
      • Toronto, Ontario, Canada, M5G1X5
        • Mount Sinai Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 55 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Kvinde

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Patients who deliver vaginally or by scheduled cesarean section at Mount Sinai Hospital.

Beskrivelse

Inclusion Criteria:

  • 18 years old and over
  • singleton births
  • 37 or more weeks gestational age
  • multiparous or nulliparous patients
  • spontaneous vaginal delivery or scheduled cesarean delivery with labor analgesia or neuraxial anesthesia
  • give informed written consent

Exclusion Criteria:

  • refusal to take part
  • are unable to give or have withdrawn consent
  • patients unable to communicate fluently in English
  • patients who are less than 18 years old
  • patients who had fetal demise or severely morbid fetal conditions such as intubation, cooling, expected surgical correction of congenital anomaly during hospitalization (although NICU admissions will be included)
  • patients who were admitted in ICU
  • patients who had failed neuraxial analgesia such as replaced epidurals or failed spinal requiring conversion to general anesthesia
  • patients who had general anesthesia for cesarean delivery as defined by "GETA", including sedatives and deep sedation if not intubated
  • patients who had intrapartum cesarean or had assisted/operative (i.e. vacuum, forceps) vaginal delivery.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Vaginal delivery

Patients who have vaginal deliveries with neuraxial labour analgesia.

PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living.

Andre navne:
  • Informationssystem til måling af patientrapporterede resultater

The WHOQOL-BREF is a 26-item version of the 100-item WHOQOL-100 quality of life measure that addresses four quality of life domains: physical health, psychological health, social relationships and environment.

Andre navne:
  • Verdenssundhedsorganisationens livskvalitet kort version

The EQ-5D-3L1 is a generic measure of health status consisting of two parts. The first part assesses health in five dimensions: MOBILITY, SELFCARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY/DEPRESSION. The second part of the questionnaire consists of a VAS on which the patient rates their perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).

Andre navne:
  • Global sundhedstilstand numerisk vurdering score 1-100
Cesarean delivery

Patients who have a scheduled cesarean delivery with neuraxial anesthesia.

PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living.

Andre navne:
  • Informationssystem til måling af patientrapporterede resultater

The WHOQOL-BREF is a 26-item version of the 100-item WHOQOL-100 quality of life measure that addresses four quality of life domains: physical health, psychological health, social relationships and environment.

Andre navne:
  • Verdenssundhedsorganisationens livskvalitet kort version

The EQ-5D-3L1 is a generic measure of health status consisting of two parts. The first part assesses health in five dimensions: MOBILITY, SELFCARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY/DEPRESSION. The second part of the questionnaire consists of a VAS on which the patient rates their perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).

Andre navne:
  • Global sundhedstilstand numerisk vurdering score 1-100

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Tidsramme: 24 hours

The PROMIS survey score at 24 hours postpartum

24 hours
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Tidsramme: 24 hours

The WHOQoLBREF survey score at 24 hours postpartum

24 hours
EQ-5D-3L1 (not an acronym) survey score
Tidsramme: 24 hours

The EQ-5D-3L1 survey score at 24 hours postpartum

24 hours
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Tidsramme: 2 weeks

The PROMIS survey score at 2 weeks postpartum

2 weeks
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Tidsramme: 2 weeks

The WHOQoLBREF survey score at 2 weeks postpartum

2 weeks
EQ-5D-3L1 (not an acronym) survey score
Tidsramme: 2 weeks

The EQ-5D-3L1 survey score at 2 weeks postpartum

2 weeks
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Tidsramme: 6 weeks

The PROMIS survey scores at 6 weeks postpartum

6 weeks
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Tidsramme: 6 weeks

The WHOQoLBREF survey score at 6 weeks postpartum

6 weeks
EQ-5D-3L1 (not an acronym) survey score
Tidsramme: 6 weeks

The EQ-5D-3L1 survey score at 6 weeks postpartum

6 weeks
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Tidsramme: 12 weeks

The PROMIS survey score at 12 weeks postpartum

12 weeks
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Tidsramme: 12 weeks

The WHOQoLBREF survey score at 12 weeks postpartum

12 weeks
EQ-5D-3L1 (not an acronym) survey score
Tidsramme: 12 weeks

The EQ-5D-3L1 survey score at 12 weeks postpartum

12 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Ronald George, MD, MOUNT SINAI HOSPITAL

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

9. juli 2025

Primær færdiggørelse (Faktiske)

16. januar 2026

Studieafslutning (Faktiske)

30. april 2026

Datoer for studieregistrering

Først indsendt

16. august 2023

Først indsendt, der opfyldte QC-kriterier

16. august 2023

Først opslået (Faktiske)

21. august 2023

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

16. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

12. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 23-03

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner